These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15785245)

  • 21. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
    Lam KY; Lo CY; Leung PS
    Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
    Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.
    Musholt TJ; Fottner C; Weber MM; Eichhorn W; Pohlenz J; Musholt PB; Springer E; Schad A
    World J Surg; 2010 Nov; 34(11):2595-603. PubMed ID: 20652698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis.
    Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A
    Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
    Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
    Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
    Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Inoue T; Tahara I; Kasai K; Hirokawa M; Tran TM; Katoh R
    Cancer Med; 2016 Aug; 5(8):1883-9. PubMed ID: 27264674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
    Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
    Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
    Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.
    Nikiforova MN; Caudill CM; Biddinger P; Nikiforov YE
    Int J Surg Pathol; 2002 Jan; 10(1):15-22. PubMed ID: 11927965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL; Zhou XY; Zhang TM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
    Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
    PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
    Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY
    Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.